opens in a new window
NEWS & MEDIA
SGS Quay Pharma’s Facility Brings Formulation and Manufacturing Expertise to North America
The need for comprehensive, technically advanced, and integrated services from contract service providers is needed now more than ever.
SGS Quay Pharma Receives Queen’s Award for Industry
SGS Quay Pharma has received its Queen’s Award for Enterprise. The award was presented by…
SGS’s Quay Pharma Collaborates to Develop New Oral Medicine for Inflammatory Bowel Disease
SGS’s Quay Pharma has partnered with Intract Pharma, CPI and Pharmidex to successfully…
New Hampshire Pharmaceutical Development and Clinical Manufacturing Facility Nears Completion
We will soon open our Hudson, NH, pharmaceutical development and clinical manufacturing facility.
SGS Quay’s Microbiome Expertise Ideal For New IBD Drug Development Project
SGS Quay Pharma is partnering on a major project to develop and commercialise an inflammatory…
Acquisition Will Further Strengthen Quay Offering
Quay Pharma has been acquired by SGS, the Swiss-based world leading (TIC) Testing, Inspection and Certification company.
Quay Pharma Wins Queen’s Award For Industry
Quay Pharmaceutical has been honoured with a Queen’s Award for Enterprise, the UK’s highest accolade for business success.
Now Recruiting in the US
Now Recruiting in the US. We have significantly extended our presence in the United States with the securing of a 55,000 sq ft facility for pharmaceutical development…
Quay Lends its Expertise to Medicines Discovery Catapult Network
Leading pharmaceutical outsourcing specialist Quay Pharma has become the first CDMO (contract development…
INSPECTED FACILITIES
